VitaDAO Founds Biotech Firm to Advance Longevity Research, Develop Treatments for Cancer and Age-related Diseases



VitaDAO, a decentralized autonomous organization (DAO), has launched Matrix Biosciences, a biotech company focused on advancing longevity research. Matrix Biosciences, majority-owned by VitaDAO, will operate as a centralized entity and work on developing treatments for cancer and age-related diseases using research on the naked mole-rat. The company aims to demonstrate the compatibility of blockchain technology with the biotech industry and is actively collaborating with regulators to ensure compliance.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 2
  • Repost
  • Share
Comment
0/400
GateUser-1515a21avip
· 01-11 18:06
Ambush 100x coin 📈
View OriginalReply0
GateUser-972b6ef8vip
· 2024-11-20 13:10
All in All in 🙌
View OriginalReply0
  • Pin
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)